| Old Articles: <Older 47011-47020 Newer> |
|---|
 |
The Motley Fool
February 8, 2011
Esterhuizen & Sellitti |
Finding a Cure for Cancer: The Option Market's Favorite Ideas What cancer stocks are investors taking seriously?: Allos Therapeutics... China Medical Technologies... Delcath Systems... Myriad Genetics... ZIOPHARM...   |
The Motley Fool
February 8, 2011
Esterhuizen & Sellitti |
Battle of the Bulge: Biotech Takes on Obesity and Diabetes Will recent advances in pharmaceutical research revolutionize the weight loss industry? It's still early days, but here are some of the stocks to watch. |
The Motley Fool
February 8, 2011
Brian Orelli |
What Will Intuitive Surgical Do for an Encore? Intuitive Surgical managed just a 10% year-over-year increase in revenue from sales of its da Vinci Surgical Systems in the fourth quarter of last year. Yet its total revenue increased a solid 21%. How? |
The Motley Fool
February 8, 2011
G. David Frye |
Amphenol Makes Boring Pay The electric connector company has similar market share to Molex but vastly better bottom line. |
The Motley Fool
February 8, 2011
David Lee Smith |
Ignoring These IPOs Will Shortchange Your Portfolio A pair of quality IPOs will add fresh opportunities for energy investors: Kinder Morgan and Kosmos Energy. |
The Motley Fool
February 8, 2011
Seth Jayson |
Green Mountain Coffee Roasters Passes This Key Test For the last fully reported fiscal quarter, Green Mountain's year-over-year revenue grew 66.6%, and its AR grew 69%. That looks OK. |
The Motley Fool
February 8, 2011
Travis Hoium |
RehabCare and Kindred Healthcare Shares Popped: What You Need to Know Shares of post-acute-care service provider RehabCare Group zoomed 43% higher today after the company announced it was being bought out by Kindred Healthcare |
The Motley Fool
February 8, 2011
Todd Wenning |
Dividend Report Card: Altria Does this tobacco giant's dividend pass the test? |
The Motley Fool
February 8, 2011
Rick Aristotle Munarriz |
Kindle Wants to Know You Better The leading online retailer hopes to make its e-reader more social. |
The Motley Fool
February 8, 2011
Esterhuizen & Sellitti |
Ready for the Biotech Century: Where's the Smart Money Going? Here's a list of four biotech stocks seeing significant institutional buying and insider buying over the last three months: Codexis... Chelsea Therapeutics... Exact Sciences... ZIOPHARM... |
| <Older 47011-47020 Newer> Return to current articles. |
